Assignee
OH SANGKON
US·1 granted patent·4 pending applications·6 citations·filing 2011–2012
Top patents by PatentIndex Score
5 records- 0176US9045542B2Controlling allergy and asthma by activating human DCs via Dectin-1 or toll-like receptor 2 (TLR2)OH SANGKON·Filed 2012·Granted Jun 2, 2015·6 cites·4 claims
- 0243US2012128710A1Enhancement of Pathogen-Specific Memory Th17 Cell ResponsesOH SANGKON·Filed 2011·Application pending·0 cites
- 0342US2012121592A1Targeting Antigens to Human Dendritic Cells Via DC-Asialoglycoprotein Receptor to Produce IL-10 Regulatory T-CellsOH SANGKON·Filed 2011·Application pending·0 cites
- 0441US2012308578A1SLE-DC-MEDIATED ENHANCED IgG- AND IgA-SECRETING B CELL RESPONSESOH SANGKON·Filed 2012·Application pending·0 cites
- 0535US2012213768A1Diagnostic and Therapeutic Uses for B Cell Maturation AntigenOH SANGKON·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when OH SANGKON files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →